Daniel Keesman, co-CEO and chief operating officer, and Martin Hollenhorst, co-CEO and chief financial officer, as well as all three members of the supervisory board of Lion Bioscience — Jurgen Dormann, Klaus Pohle, and Richard Roy — have resigned. Thure Etzold, managing director for Lion Bioscience UK, and Joseph Donahue, chief business officer for Lion Bioscience in North America, have been appointed as co-CEOs. Etzold will be responsible for product development and services, and Donahue will assume responsibility for finance and administration. See story, p. 1, for further details.
Daniel Keesman, Martin Hollenhorst, Jurgen Dormann, Klaus Pohle, Richard Roy, Thure Etzold, Joseph Donahue
Oct 18, 2004